Lilly's EloraTZP pairs tirzepatide with eloralintide in a Phase 2b trial
The experimental combo adds Lilly's amylin drug eloralintide to the active ingredient in Zepbound and Mounjaro, and posted strong weight loss in mid-stage testing.
Recap by typeshit. Post by @alchetron_com on Instagram.